Marshall Wace LLP Acquires 343,692 Shares of DocGo Inc. (NASDAQ:DCGO)

Marshall Wace LLP lifted its holdings in DocGo Inc. (NASDAQ:DCGO) by 212.4% during the second quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 505,514 shares of the company’s stock after purchasing an additional 343,692 shares during the quarter. Marshall Wace LLP owned 0.50% of DocGo worth $1,562,000 as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in DCGO. nVerses Capital LLC increased its stake in DocGo by 151.5% in the 2nd quarter. nVerses Capital LLC now owns 8,300 shares of the company’s stock valued at $26,000 after buying an additional 5,000 shares during the last quarter. Nisa Investment Advisors LLC grew its holdings in shares of DocGo by 693.2% in the 2nd quarter. Nisa Investment Advisors LLC now owns 12,089 shares of the company’s stock valued at $37,000 after acquiring an additional 10,565 shares in the last quarter. Gladius Capital Management LP acquired a new stake in shares of DocGo in the second quarter valued at about $34,000. Price T Rowe Associates Inc. MD raised its holdings in DocGo by 31.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 47,216 shares of the company’s stock worth $191,000 after acquiring an additional 11,174 shares in the last quarter. Finally, Victory Capital Management Inc. raised its holdings in DocGo by 124.0% during the second quarter. Victory Capital Management Inc. now owns 25,635 shares of the company’s stock worth $79,000 after acquiring an additional 14,191 shares in the last quarter. Institutional investors and hedge funds own 56.44% of the company’s stock.

DocGo Stock Up 6.3 %

DCGO opened at $3.35 on Friday. DocGo Inc. has a 12-month low of $2.75 and a 12-month high of $6.90. The business has a 50 day moving average of $3.49 and a 200-day moving average of $3.38. The stock has a market cap of $340.25 million, a price-to-earnings ratio of 16.75, a PEG ratio of 2.96 and a beta of 0.91.

DocGo (NASDAQ:DCGO) last announced its quarterly earnings results on Wednesday, August 7th. The company reported $0.06 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.07 by ($0.01). The business had revenue of $164.95 million for the quarter, compared to analyst estimates of $166.61 million. DocGo had a net margin of 3.97% and a return on equity of 8.90%. As a group, analysts expect that DocGo Inc. will post 0.23 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have weighed in on DCGO shares. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $5.00 price target on shares of DocGo in a research report on Friday, September 20th. Needham & Company LLC restated a “buy” rating and set a $7.00 target price on shares of DocGo in a report on Thursday, August 8th. Five equities research analysts have rated the stock with a buy rating, According to data from MarketBeat, the stock has an average rating of “Buy” and a consensus price target of $6.10.

About DocGo

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.